Innovent Biologics, Inc. (IVBXF)
11.01
-1.33
(-10.80%)
USD |
OTCM |
Sep 16, 16:00
Innovent Biologics Market Cap : 19.09B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 19.09B |
| September 15, 2026 | 21.40B |
| September 14, 2026 | 20.40B |
| September 11, 2026 | 20.40B |
| September 10, 2026 | 20.82B |
| September 09, 2026 | 21.96B |
| September 08, 2026 | 22.87B |
| September 04, 2026 | 22.74B |
| September 03, 2026 | 22.27B |
| September 02, 2026 | 22.27B |
| September 01, 2026 | 22.27B |
| August 31, 2026 | 24.76B |
| August 28, 2026 | 26.03B |
| August 27, 2026 | 24.64B |
| August 26, 2026 | 24.64B |
| August 25, 2026 | 23.07B |
| August 24, 2026 | 23.61B |
| August 21, 2026 | 20.48B |
| August 20, 2026 | 21.52B |
| August 19, 2026 | 21.52B |
| August 18, 2026 | 21.52B |
| August 17, 2026 | 21.46B |
| August 14, 2026 | 21.46B |
| August 13, 2026 | 21.46B |
| August 12, 2026 | 21.46B |
| Date | Value |
|---|---|
| August 11, 2026 | 21.46B |
| August 10, 2026 | 21.51B |
| August 07, 2026 | 21.44B |
| August 06, 2026 | 21.30B |
| August 05, 2026 | 19.63B |
| August 04, 2026 | 18.53B |
| August 03, 2026 | 18.53B |
| July 31, 2026 | 18.62B |
| July 30, 2026 | 21.07B |
| July 29, 2026 | 21.67B |
| July 28, 2026 | 21.37B |
| July 27, 2026 | 17.90B |
| July 24, 2026 | 18.79B |
| July 23, 2026 | 22.20B |
| July 22, 2026 | 22.20B |
| July 21, 2026 | 18.84B |
| July 20, 2026 | 22.49B |
| July 17, 2026 | 20.82B |
| July 16, 2026 | 22.20B |
| July 15, 2026 | 20.00B |
| July 14, 2026 | 18.92B |
| July 13, 2026 | 18.90B |
| July 10, 2026 | 19.76B |
| July 09, 2026 | 19.68B |
| July 08, 2026 | 19.60B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 1.088B |
| CStone Pharmaceuticals Co. Ltd. | 1.343B |
| RemeGen Co., Ltd. | 6.130B |
| InnoCare Pharma Ltd. | 2.735B |
| Adagene, Inc. | 212.84M |
Market Cap Related Metrics
| PE Ratio | 110.39 |
| PS Ratio | 8.645 |
| Price | 11.01 |
| Earnings Yield | 0.91% |
| Operating PE Ratio | 51.18 |
| Normalized PE Ratio | 108.11 |